Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) SHH

32.35

-0.09(-0.28%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap3.33B
Enterprise Value3.51B
P/E Ratio29.51
PEG Ratio32.46
Price/Sales Ratio3.33
Price/Book Ratio2.52
Enterprise/Revenue3.51
Enterprise/EBITDA21.61

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.11
Operating Margin0.12

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue1.3B
Revenue/Share9.7
Gross Profit367.27M
EBITDA302.58M
Net Income146.42M
Diluted EPS1.08

Balance Sheet

Total Cash243.39M
Total Cash/Share2.63
Total Debt483.1M
Total Debt/Equity0.28
Current Ratio1.26
Book Value Per Share12.87

Price History

52-Week Change60.8
52-Week High33.34
52-Week Low18.81
Moving Average 50 Days29.27
Moving Average 200 Days26.24

Statistics

Average Volume2.54M
Shares Outstanding135.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield1.24
Payout Ratio0.37
Last Split Factor7:5
Last Split DateMay 27, 2020